Tyrosine kinase inhibitors as next generation oncological therapeutics: Current strategies, limitations and future perspectives
Protein kinases, a class of enzymes that govern various biological phenomena at a cellular
level, are responsible for signal transduction in cells that regulate cellular proliferation …
level, are responsible for signal transduction in cells that regulate cellular proliferation …
Current progress towards the development of tyrosine kinase inhibitors as anticancer agents
AJ Bridges - Emerging drugs, 1998 - Taylor & Francis
Tyrosine kinases (TKs) are a large subfamily of the largest known gene family, the kinases,
of which the human genome is now estimated to contain in excess of 2,000 [1]. TKs catalyse …
of which the human genome is now estimated to contain in excess of 2,000 [1]. TKs catalyse …
[HTML][HTML] Utilization of kinase inhibitors as novel therapeutic drug targets: A review
Kinase inhibitors are a significant and continuously developing division of target
therapeutics. The drug discovery and improvement efforts have examined numerous …
therapeutics. The drug discovery and improvement efforts have examined numerous …
Receptor tyrosine kinases and anticancer therapy
M Medinger, J Drevs - Current pharmaceutical design, 2005 - ingentaconnect.com
Receptor and non-receptor protein tyrosine kinases (PTKs) are essential enzymes in cellular
signaling processes and signal transduction pathways that regulate cell growth …
signaling processes and signal transduction pathways that regulate cell growth …
Tyrosine kinase inhibitors and their unique therapeutic potentialities to combat cancer
Cancer is one of the leading causes of death with a mortality rate of 12%. Although
significant progress has been achieved in cancer research, the effective treatment of cancer …
significant progress has been achieved in cancer research, the effective treatment of cancer …
Overcoming the drug resistance problem with second-generation tyrosine kinase inhibitors: from enzymology to structural models
Protein phosphorylation is one of the major pathways used by eukaryotic cells to propagate
signals to the final effectors, regulating multiple aspects of the living cell, such as …
signals to the final effectors, regulating multiple aspects of the living cell, such as …
Role of tyrosine kinase inhibitors in cancer therapy
A Arora, EM Scholar - Journal of Pharmacology and Experimental …, 2005 - ASPET
Cancer chemotherapy has been one of the major medical advances in the last few decades.
However, the drugs used for this therapy have a narrow therapeutic index, and often the …
However, the drugs used for this therapy have a narrow therapeutic index, and often the …
Cancer management by tyrosine kinase inhibitors: efficacy, limitation, and future strategies
VWT Ho, HY Tan, N Wang, Y Feng - Tyrosine Kinases as …, 2019 - books.google.com
Tyrosine kinase inhibitors are taking up an increasingly significant role in treating cancers.
There are different types of TKIs currently used in clinical settings. However, TKI-associated …
There are different types of TKIs currently used in clinical settings. However, TKI-associated …
[PDF][PDF] Tyrosine Kinases: promising targets for cancer chemotherapy
VS Kasture, DS Musmade, SJ Aher… - Med Chem Drug Discov, 2012 - academia.edu
Cancer chemotherapy has been one of the major medical advances in the last few decades.
However, the drugs used for this therapy have a narrow therapeutic index, and often the …
However, the drugs used for this therapy have a narrow therapeutic index, and often the …
Tyrosine kinase inhibitors in cancer therapy
S Madhusudan, TS Ganesan - Clinical biochemistry, 2004 - Elsevier
Cancer is the second leading cause of death in the western world. Despite advances in
diagnosis and treatment, overall survival of patients remains poor. Scientific advances in …
diagnosis and treatment, overall survival of patients remains poor. Scientific advances in …